🔄 Opioid / Benzodiazepine Antagonists
UseReverse opioid or benzodiazepine effects when indicated; supportive care (airway/ventilation) is often the sa…
SourceAHA ACLS and toxicology references on antagonist use
This-shift next steps
After scoring: open the scene pack, peer scores, and the matching pathway. Local reference — no HIS write.
Paste the link in Slack, Teams, X, or LinkedIn — the preview image comes from this page’s Open Graph card.
Methodology · worked example, guidelines & full notes
Naloxone precipitates withdrawal in dependence — titrate from a small dose.
When to use
Reverse opioid or benzodiazepine effects when indicated; supportive care (airway/ventilation) is often the safer choice.
How it works
Naloxone 0.04–0.4 mg IV titrated q2–3min. Flumazenil 0.2 mg IV → 0.1–0.2 mg q1min, usually max ~1 mg.
Key points
- Naloxone precipitates withdrawal in dependence — titrate from a small dose.
- Flumazenil is not for diagnostic use in undifferentiated coma.
- Avoid flumazenil with seizure risk, TCA co-ingestion or QRS > 100 ms.
- Both antagonists are shorter-acting than the parent drug — watch for re-depression/re-sedation.
References
- [Guideline / primary source]AHA ACLS and toxicology references on antagonist use
Worked calculation
The values below come from this tool's own example placeholders and are computed server-side with the formula shown on this page, so the arithmetic can be checked quickly. It demonstrates how to substitute values only — it is not clinical advice and not a real case.
| Antagonist | Naloxone (opioid) |
|---|
→AntagonistNaloxone (opioid antagonist)
- Indication：Opioid-induced respiratory depression/coma
- Dose：0.04–0.4 mg IV titrated q2–3min to adequate ventilation; if no IV, IM/intranasal (4 mg)
- Long-acting opioids：Short effect (30–90 min) with risk of re-sedation; repeat or infuse ~2/3 of the effective dose per hour
| Antagonist | Flumazenil (benzodiazepine) |
|---|
→AntagonistFlumazenil (benzodiazepine antagonist)
- Indication：Mainly reversing iatrogenic sedation in non-dependent patients; supportive care is first-line for BZD overdose
- Dose：0.2 mg IV (15 s) → 0.1–0.2 mg q1min, usually max ~1 mg (rarely up to 3–5 mg)
- Contraindications/caution：Chronic dependence, seizures/antiepileptic use, co-ingestion of proconvulsants like TCAs, QRS > 100 ms, undifferentiated coma
Verification & sources · governance
FAQ
Frequently asked questions
- What are the limits and cautions when using Opioid / Benzodiazepine Antagonists?
- For licensed clinicians and clinical researchers. Interpret results with history, investigations and local protocols; not a diagnosis or prescription, and not a substitute for multidisciplinary decision-making or local guidelines.
- Does Opioid / Benzodiazepine Antagonists upload patient data? Where is it calculated?
- Calculation runs locally in the browser; inputs and results are not uploaded. For licensed clinicians only; interpret with history, investigations and local protocols — not a diagnosis or prescription.
- How is Opioid / Benzodiazepine Antagonists calculated in practice? Can you show a worked example?
- Inputs: Antagonist Naloxone (opioid) → Result: Antagonist Naloxone (opioid antagonist)（Indication: Opioid-induced respiratory depression/coma, Dose: 0.04–0.4 mg IV titrated q2–3min to adequate ventilation; if no IV, IM/intranasal (4 mg), Long-acting opioids: Short effect (30–90 min) with risk of re-sedation; repeat or infuse ~2/3 of the effective dose per hour） Inputs: Antagonist Flumazenil (benzodiazepine) → Result: Antagonist Flumazenil (benzodiazepine antagonist)（Indication: Mainly reversing iatrogenic sedation in non-dependent patients; supportive care is first-line for BZD overdose, Dose: 0.2 mg IV (15 s) → 0.1–0.2 mg q1min, usually max ~1 mg (rarely up to 3–5 mg), Contraindications/caution: Chronic dependence, seizures/antiepileptic use, co-ingestion of proconvulsants like TCAs, QRS > 100 ms, undifferentiated coma）